We are pleased to announce our 2018 World Preclinical Congress Distinguished Faculty:

Aaron Wright, PhD, Principal Investigator and Group Leader, Chemical Biology & Exposure Sciences Group, Pacific Northwest National Laboratory

Adam S. Lazorchak, PhD, Senior Scientist, Immunology & Translational Sciences, Curis, Inc.

Alain Brisson, PhD, Emeritus Professor, UMR-CBMN CNRS, University of Bordeaux

Alejandro Villagra, PhD, Assistant Professor, Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University

Aleksandra Baranczak, PhD, Senior Scientist, Chemistry and Chemical Biology, AbbVie

Alex Chenchik, PhD, President, CSO, Cellecta, Inc.

Alex Walsh, PhD, Assistant Scientist, Department of Medical Engineering, Morgridge Institute for Research, University of Wisconsin - Madison

Alexander Baker, Research Scientist, Molly Shoichet Laboratory, Institute of Biomaterials and Biomedical Engineering, Chemical Engineering & Applied Chemistry, The Donnelly Centre, University of Toronto

Alexander (Sasha) Kabanov, PhD, DrSci, MAE, Director, Center for Nanotechnology in Drug Delivery; Co-Director, Carolina Institute for Nanomedicine; Mescal S. Ferguso Distinguished Professor, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill

Alyssa Schwartz, Graduate Research Assistant, Chemical Engineering, University of Massachusetts Amherst

Amanda Benjamin, Head, Alliance and Project Management, Drug Safety and Metabolism, AstraZeneca

Amantha Thathiah, PhD, Assistant Professor, Department of Neurobiology, Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine

Anand Subramony, PhD, Vice President, Novel Product Technologies, MedImmune

Andrea Alms, Consultant, Molding Component Business Department, Kuraray Co. Ltd

Andrew Hoffman, DVM, DVSc, Diplomate ACVIM, Director of the Regenerative Medicine Laboratory, Professor, Large Animal Medicine, Department of Clinical Sciences, Tufts University Cummings School of Veterinary Medicine

Andrew Hope, PhD, Vice President, Business Development, Cyclica Inc

Andrew Sawyer, PhD, Research Team Lead, Discovery, Merrimack

Andrew Weinberg, PhD, Chief, Laboratory of Basic Immunology, Providence Health & Services

Andrew Whale, PhD, Senior Scientist, Manager, Preclinical, Immunocore Ltd.

Anita Seshire, PhD, Lab Head, Cellular Pharmacology, Translational Innovation Platform Oncology, Merck KGaA

Anja Baumgart, Business Development Manager, Sales, ProQinase

Anna Jezierski, PhD, Research Associate, Human Health Therapeutics, National Research Council of Canada

Anne Mai Wassermann, PhD, Associate Principal Scientist, Cheminformatics, Merck

Annette Gilchrist, PhD, Professor, Pharmacology, Midwestern University

Arantza Muriana, MBA, CEO, Biobide USA

Arijit Chakravarty, CEO, Fractal Therapeutics

Arvind Rao, PhD, Assistant Professor, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center

Asano Asami-Odaka, PhD, Associate Director, Ikeya Project, T-CiRA, Regenerative Medicine Unit, Takeda Pharmaceutical Company Limited

Ashley Rae Kark, MBS, Director, Corporate Relations, Scientist.com

Atli Thorarensen, PhD, Research Fellow, BioTc Medicinal Chemistry, Pfizer

Avi Smith, MA, Senior Research Technician, Tufts University

Baptiste Lacoste, PhD, Assistant Professor, Cellular and Molecular Medicine/Neuroscience Program, The University of Ottawa/Ottawa Hospital Research Institute

Barbara Joyce-Shaikh, Associate Principal Scientist, Merck Research Laboratories

Barbara K. Sosnowski, PhD, Vice President and Global Head, External R&D Innovation, Pharmatherapeutics and WRD External Partnerships, Pfizer, Inc.

Barry Morgan, PhD, Professor, Center for Drug Discovery, Bayer College of Medicine

Benjamin Cuiffo, PhD, Principal Scientist, Oncology, Biomodels, LLC

Bhagat Singh, PhD, Research Fellow, Neurobiology, Clifford Wolf’s Lab, Boston Children’s Hospital, Harvard Medical School

Bilada Bilican, PhD, Investigator II, Neuroscience, Novartis Institutes for BioMedical Research (NIBR)

Brandon Farley, PhD, Senior Scientist, SAGE Therapeutics

Britnie James, PhD, Senior Vice President, Pre-Clinical Services, Immunology and Oncology, Pre-Clinical Laboratory Services, MD Biosciences, Inc.

Caghan Kizil, PhD, Helmholtz Young Investigator Group Leader, German Center for Neurodegenerative Diseases (DZNE) within Helmholtz Association

Carlo Cusulin, PhD, Senior Scientist, Disease Relevant Cellular Assays, Chemical Biology, F. Hoffmann-La Roche

Catherine Lebrun, PhD, Medicinal Chemist, Medicinal Chemistry, EMD-SERONO

Chao Ma, PhD, Postdoc, Weiqiang Chen Laboratory, Department of Mechanical and Aerospace Engineering, New York University

Chao Zhou, PhD, Associate Professor, Founding Member, Department of Bioengineering, Department of Electrical and Computer Engineering, Lehigh University

Chee Yeun Chung, PhD, Scientific Co-Founder and Associate Director, Discovery Biology, Yumanity Therapeutics

Chen Zhu, PhD, Lab Head, Sanofi Oncology

Choi-Fong Cho, PhD, Instructor, Department of NeurosBaptiste Lacoste, PhD, Assistant Professor, Cellular and Molecular Medicine/ Neuroscience Program, The University of Ottawa/Ottawa Hospital Research Institute

Christian Klose, PhD, Head, Research and Development, Lipotype GmbH

Christopher Hartshorn, PhD, Program Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute

Christopher Untucht, PhD, Senior Scientist, Head of Cell Imaging Platform, Neuroscience Discovery Core Technologies, AbbVie Deutschland GmbH & Co. KG

Chulhee Choi, MD, PhD, Professor, Department of Bio and Brain Engineering, KAIST, Korea

Craig W. Lindsley, PhD, Vanderbilt Center for Neuroscience Drug Discovery

Cynthia Reinhart-King, PhD, Cornelius Vanderbilt Professor of Engineering, Biomedical Engineering, Vanderbilt University

Dana Larocca, PhD, Vice President, Discovery Research, AgeX Therapeutics, Inc.

Daniel Haag, PhD, CSO, NeuCyte, Inc.

Daniel Irimia, MD, PhD, Associate Professor, Division of Surgery, Science & Bioengineering, Massachusetts General Hospital, Harvard Medical School, and Shriners Hospitals for Children – Boston

Daniel V. LaBarbera, PhD, Associate Professor, Drug Discovery and Medicinal Chemistry; Director, High-Throughput Screening and Chemical Biology Core Facility, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado

Daniel Nomura, PhD, Associate Professor, Chemistry, Molecular and Cell Biology, and Nutritional Sciences and Toxicology, University of California, Berk

Danilo A. Tagle, PhD, Associate Director for Special Initiatives, National Center for Advancing Translational Sciences, National Institutes of Health

Danilo Maddalo, PhD, Lab Head, ONC Pharmacology, Novartis Institutes for BioMedical Research, Novartis Pharma AG

Danilo Tagle, PhD, Associate Director for Special Initiatives, Office of the Director, National Center for Advancing Translational Sciences, National Institutes of Health

Dario Doller, PhD, Sage Therapeutics

David Barbie, MD, Assistant Professor, Medical Oncology, Dana-Farber Cancer Institute

David Duignan, PhD, Principal Research Scientist, Drug Metabolism, Pharmacokinetics & Bioanalysis, AbbVie Bioresearch Center

David J. Echevarria, PhD, Associate Professor, Director, Behavioral Neuroscience Laboratory, Department of Psychology, University of Southern Mississippi

David Nguyen, PhD, Principal Scientist, SAGE Therapeutics

David Schaer, Principal Research Scientist, Cancer Immunobiology Experimental and Translational Immuno-Oncology Group, Eli Lilly and Company

Dazhong Xu, PhD, Assistant Professor of Pathology, Vice Chair of Research, Department of Pathology, New York Medical College School of Medicine

Deborah Pre, PhD, Scientist, Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute

Deepak Kumar Rajpal, Ph.D., Director, Computational Biology, GlaxoSmithKline

Denise Barrault, PhD, Executive Director, National Phenotypic Screening Centre

Denise L. Faustman, MD, PhD, Director, Immunobiology, Massachusetts General Hospital; Associate Professor, Medicine, Harvard Medical School

Dimitrios Tzalis, PhD, CEO, Taros Chemicals GmbH & Co. KG

Donglu Zhang, PhD, Senior Scientist, Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.

Doo Yeon Kim, PhD, Assistant Professor of Neurology, Genetics and Aging Research Unit, Massachusetts General Hospital / Harvard Medical School

Doug Johnson, PhD, Research Fellow, Head of Chemical Biology, Pfizer Worldwide Research & Development

Duncan Armstrong, PhD, PreClinical Safety, Novartis Institutes for BioMedical Research

Edgar Wood, Senior Research Director, Discovery, Charles River

Edward J. Hennessy, PhD, Associate Principal Scientist, Oncology iMed, AstraZeneca

Ekta Kadakia, MS, Scientist 1, DMPK, Takeda

Elisa Konofagou, Professor, Biomedical Engineering, Columbia University

Elizabeth Evans, PhD, Vice President, Preclinical Research, Vaccinex, Inc.

Emer Leahy, PhD, President, CEO, PsychoGenics Inc.

Eric Goedken, PhD, Principal Scientist, Foundational Immunology, AbbVie Bioresearch Center

Eric Karran, PhD, Vice President, Foundational Neuroscience Center, AbbVie Neuroscience, AbbVie

Eric Marsault, PhD, Professor, Medicinal Chemistry and Pharmacology, University of Sherbrooke

Fabian Zanella, Director, Research & Development, StemoniX

Fabien Vincent, PhD, Associate Research Fellow, Hit Discovery and Lead Profiling Group, Pfizer

Fangxian (Frank) Sun, Lead Research Investigator, Pharmacology, Sanofi

Francisco Garcia, PhD, Associate Scientist/Postdoctoral Research Fellow, Chemical Biology and Proteomics, Merck Research Laboratories

Ganesh Rajaraman, PhD MBA, Associate Director, DMPK, Celgene Corporation

Gary Gintant, PhD, Senior Research Fellow, Department of Integrative Pharmacology, Integrated Science and Technology, AbbVie

Geoffrey Bartholomeusz, PhD, Associate Professor and Director, Target Identification and Validation Program, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Georgette L. Suidan, PhD, Principal Scientist, Lab Head, Internal Medicine Research Unit, Pfizer, Inc.

Gopi Shanker, PhD, Head of Psychiatry, Neuroscience Department, Novartis Institutes for Biomedical Research (NIBR)

Graham Dempsey, PhD, Vice President, Research and Development, Q-State Biosciences

Greg Johnson, PhD, Scientist & Machine Learning Specialist, Allen Institute for Cell Science

Gregory Tietjen, PhD, Assistant Professor, Department of Surgery, Section of Transplantation and Immunology, Yale School of Medicine

Guido Grandi, PhD, Professor, Synthetic and Structural Vaccinology - CIBIO, University of Trento, Formerly Senior Project Leader, Novartis Vaccines and Diagnostics

Gulden Camci-Unal, PhD, Assistant Professor, Chemical Engineering, University of Massachusetts Lowell

Gus Frangou, PhD, Assistant Professor of Oncology, Department of Cancer Genetics, Roswell Park Cancer Institute; Senior Fellow, Harvard T.H. Chan School of Public Health

H. James Harwood Jr., PhD, Founder and CEO, Delphi BioMedical Consultants, LLC

Helmut Thomas, PhD, DABT, President and CEO, Cyclenium Pharma, Inc.

Hicham Fenniri, PhD, Professor, Chemical and Biomedical Engineering, Northeastern University

Hossein Tavana, PhD, PEng, Associate Professor, Department of Biomedical Engineering, The University of Akron

Ibrahim Domian, MD, PhD, Assistant Physician, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School

Istvan Enyedy, PhD, Principal Scientist, Medicinal Chemistry, Biogen

Ivan Cornella Taracido, PhD, Director, Chemical Biology, Merck Research Laboratories

J. Henri Bayle, PhD, Director of Discovery, Bellicum Pharmaceuticals, Inc.

Jacob M. Hooker, PhD, Phyllis and Jerome Lyle Rappaport MGH Research Scholar, Associate Professor of Radiology, Harvard Medical School

James Dahlman, PhD, Assistant Professor, Department of Biomedical Engineering, Georgia Institute of Technoloy/Emory Medical School

James J. Hickman, PhD, Founding Director, NanoScience Technology Center; Professor, Nanoscience Technology, Chemistry, Biomolecular Science, Material Science and Electrical Engineering, University of Central Florida

Jan Lötvall, MD, PhD, Professor, Krefting Research Centre, University of Gothenburg; Senior Consultant, Codiak BioSciences, Inc.

Janica Wong, PhD, Senior Scientist, Translational Pathology, Merck Research Labs

Jean Viallet, PhD, CEO, CSO, Inovotion

Jeff Borenstein, PhD, Laboratory Technical Staff, Biomedical Microsystems, Draper

Jeffrey Borenstein, PhD, Laboratory Technical Staff, Biomedical Microsystems, Draper

Jennifer Brogdon, PhD, Director, Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research

Jennifer Mataraza, PhD, Group Lead, Translational Immuno-Oncology, Novartis Institutes for BioMedical Research

Jennifer Smith, PhD, Deputy Director, ICCB-Longwood Screening Facility, Harvard Medical School

Jens Eckstein, PhD President, SR One

Jeremey Edmunds, PhD, Director, Immunology Medicinal Chemistry, AbbVie

Jeremy Jenkins, PhD, Executive Director, Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research

Jerome Mertens, PhD, Salk Institute

Jesus Medina, PhD, Manager, Medicinal Chemistry, GlaxoSmithKline

Jialin Mao, PhD, Senior Scientist, DMPK, Genentech

Jiangbing Zhou, Assistant Professor of Neurosurgery and of Biomedical Engineering, Department of Neurosurgery, Yale University

Jinjun Shi, PhD, Assistant Professor, Harvard Medical School; Director, Laboratory for Nanoengineering & Drug Delivery, Brigham and Women’s Hospital

Joern Hopke, PhD, Senior Research Investigator, Sanofi Biologics Research

Johan Luthman, PhD, Vice President, Neuroscience Clinical Development, Neurology Business Group, Eisai, Inc.

Johannes Grosse, PhD, Director, Neuroscience Drug Discovery/Alliances, Takeda

John Doench, PhD, Associate Director, Genetic Perturbation Platform, Broad Institute of Harvard and MIT

John Feder, PhD, Associate Director of Genome Biology and Emerging Technologies, Department of Genetically Defined Diseases and Genomics, Bristol-Myers Squibb

John Gregory, Director, R&D Project & Portfolio Management Business Technology, Pfizer

John MacMillan, PhD, Professor, Chemistry and Biochemistry, University of California, San Diego

John Mathias, PhD, Senior Director, Head of Inflammation & Immunology Design, Pfizer

John Pezacki, PhD, Professor, Chemistry and Biomolecular Sciences, University of Ottawa

John Reilly, PhD, Senior Research Investigator, Global Chemistry, Novartis

John Swart, PhD, President, Exemplar Genetics

John Wambaugh, PhD, Physical Scientist, National Center for Computational Toxicology, U.S. Environmental Protection Agency

Jonathan Dry, Principal Scientist, Bioinformatics, Oncology, Innovative Medicines & Early Development, AstraZeneca

Jonathan Garlick, DDS, PhD, Professor, School of Dental Medicine, Tufts University; Director, Division of Cancer Biology and Tissue Engineering, Tufts School of Medicine, School of Engineering and Sackler School of Graduate Biomedical Sciences

Jonathan Shewring, PhD, Field Application Specialist, ONI

Joseph Bonventre, MD, PhD, Chief of the Renal Unit, Director of the Bioengineering Division, Brigham and Women’s Hospital

Joseph Charest, PhD, Program Manager, Commercial Programs, Draper

Joseph Moskal, PhD., CSO, Aptinyx

Karen DeBalsi, PhD, Study Director, Metabolon

Karin Enell Smith, PhD, Senior Scientist, Preclinical Development, Alligator Bioscience AB

Katherine Chiappinelli, PhD, Assistant Professor, Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University

Keisuke Yanagida, PhD, Research Fellow, Vascular Biology Program, Boston Children’s Hospital/Harvard Medical School

Keith L. Ligon, MD, PhD, Director, Department of Oncologic Pathology, Center for Patient Derived Models, Dana-Farber Cancer Institute

Ken Hance, Senior Director & Head, Immune Biology, Immuno-Oncology & Combinations Discovery Performance Unit, GlaxoSmithKline

Kent Werner, MD, PhD, Co-Founder and CEO, Cogentis Therapeutics; Johns Hopkins Neurology Adjunct Faculty

Kevin Bitterman, PhD, Partner, Atlas Venture

Kevin Holden, PhD, Head, Synthetic Biology, Synthego

Kilian Huber, PhD, Principal Investigator, Structural Genomics Consortium (SGC), Target Discovery Institute, Nuffield Department of Medicine, University of Oxford

Kin-Hoe Chow, PhD, Associate Director, Center for Patient Derived Models, Dana-Farber Cancer Institute

Kuan-Chun Su, PhD, Post-doctoral Fellow, Laboratory of Iain Cheeseman, Department of Biology, MIT and Whitehead Institute

Laszlo Urban, MD, PhD, Global Head, Preclinical Secondary Pharmacology, Novartis Institutes for Biomedical Research

Leigh Zawel, PhD, Managing Director, MPM Capital

Leo Chan, Technology Research & Development Manager, Nexcelom Bioscience LLC

Leo Price, PhD, CEO, OcellO

Li Di, PhD, Research Fellow, Pharmacokinetics, Dynamics and Metabolism, Pfizer

Li Peng, PhD, Vice President, Biotherapeutics Discovery, Palleon Pharmaceuticals

Lijun Sun, PhD, Director, Center for Drug Discovery and Translational Research, Beth Israel Deaconess Medical Center, Harvard Medical School

Lorraine Irving, PhD, Research Scientist, MedImmune

Lyn Jones, PhD, Vice President, Chemistry and Chemical Biology, Jnana Therapeutics

Madhu Lal-Nag, PhD, Group Leader, Trans-NIH RNAi Facility, National Center for Advancing Translational Sciences, National Institutes of Health

Marc Ferrer, PhD, Team Lead, NIH Chemical Genomics Center, NCATS, NIH

Marco Ruella, MD, Clinical Instructor, Associate Director, Dr. June’s Laboratory, Center for Cellular Immunotherapies (CCI), Perelman School of Medicine, University of Pennsylvania

Marcus Bosenberg, MD, PhD, Associate Professor, Dermatology and Pathology, Yale University, Co-Leader, Genomics, Genetics and Epigenetics Program, Yale Cancer Center

Margaret Prendergast, Director, Bioengineering, Allevi, Inc.

Margarida Barroso, PhD, Associate Professor, Department of Molecular and Cellular Physiology, Albany Medical College

Maria A. Miteva, PhD, Research Director, Molécules Thérapeutiques in silico (MTi), Inserm Institute

Maria Karasarides, PhD, Executive Director, Immuno-Oncology, Regeneron Pharmaceuticals

Mario Gimona, PhD, Head of Production GMP & Head of Research Program “Nanovesicular Therapeutics”, GMP Unit, Paracelsus Medical University Salzburg

Mark A. Murakami, MD, Instructor in Medicine, Department of Medical Oncology, Dana-Farber Cancer Institute

Mark Paris, PhD, Associate Director, Translational Applications, Mitra Biotech

Mark Peterson, PhD, COO, Cyclenium Pharma, Inc.

Maryam Clausen, PhD, Senior Research Scientist, Translational Genomics, Discovery Sciences, Innovative Medicines and Early Development Biotech Unit (iMed), AstraZeneca

Matt Wagoner, Associate Director, Mechanistic and Investigative Toxicology, Takeda Pharmaceuticals

Matthew M. Hewitt, PhD, Principal Scientist, Tumor Biology & Director, Tumor Immunology/Microenvironment, Research & Development, Bellicum Pharmaceuticals, Inc.

Maude Tessier, Executive Director, Business Development, Merck

Max Woolley, PhD, BEng (Hons), BEng, Neuro Applications, Renishaw plc

Meir Glick, PhD, Director, Informatics, Chemistry, Merck Research Laboratories

Melissa Thomas, MD, PhD, Medical Fellow, Diabetes and Complications, Eli Lilly and Company

Michael Gladstone, MD, Principal, Atlas Venture

Michael Hiatt, PhD, Senior Scientist, Research & Development, STEMCELL Technologies Inc.

Michael Sasner, PhD, Co-Director, Disease Modeling Program, MODEL-AD Cente

Michael Woo, PharmD, MBA, Head, Search & Evaluation, Immuno-Oncology, External Innovation, EMD Serono Research & Development Institute

Mingxiang Liao, PhD, Associate Director, Clinical Pharmacology and DMPK, Clovis Oncology

Mithun Khattar, PhD, Immuno-Oncology Lead, Cancer Pharmacology, Takeda Pharmaceuticals

Monica Moya, PhD, Research Engineer, Materials Engineering Division, Lawrence Livermore National Laboratory

Moony (Yuen-Yi) Tseng, PhD, Group Leader, Research Scientist, Cancer Program, The Broad Institute of MIT and Harvard

Morteza Mahmoudi, PhD, Instructor, Center for Nanomedicine and Department of Anesthesiology, BWH, Harvard Medical School

Murali Gopalakrishnan, PhD, MBA, Senior Director, Head, Search & Evaluation Neuroscience, AbbVie

Neil Grimster, Senior Scientist, Oncology Chemistry, AstraZeneca

Nick Iannotti, PhD, Manager, Precision Medicine Technology, R&D Business Technology, Pfizer

Nicole Meisner-Kober, PhD, Scientific Director, Research Studios Austria, University of Salzburg, Formerly Senior Investigator, Novartis Institutes for Biomedical Research

Niek Dekker, PhD, Principal Scientist, Discovery Sciences, AstraZeneca

Nikolai Tupitsyn, PhD, Professor, Cancer Immunology, Lab, Blokhin Cancer Research Center

Nilesh Kumar, PhD, Partner, Novo Ventures

Nisha S. Sipes, PhD, Health Science Evaluator, Biomolecular Screening Branch/Toxicoinformatics Group, National Toxicology Program Division, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health

Norman Greenberg, PhD, CSO and Senior Vice President, Therapeutics, Atreca

Oleg Butovsky, PhD, Assistant Professor of Neurology, Harvard Medical School, Associate Scientist, Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital

Patrick Mayes, PhD, Executive Director, Head, IO Antibody Research, Incyte

Paul Robbins, PhD, Professor and Director of the TSRI Center on Aging, Molecular Medicine, The Scripps Research Institute

Paul Trippier, PhD, Professor, Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center

Peter Lobel, PhD, Professor, Center for Advanced Biotechnology and Medicine, Rutgers University

Peter Reinhardt, PhD, Head, Cell Programming and Transduction, Technology Core, Neuroscience Discovery, AbbVie

Peter Searson, PhD, Professor, Institute for Nanobiotechnology, Johns Hopkins University

Peter Tonge, PhD, Professor, Chemistry, Stony Brook University

Philip Carpino, PhD, Associate Research Fellow, Medicine Design, Pfizer

Philippe Slos, PhD, Study Director, Oncodesign

Ping Chiao, PhD, Senior Director, Translational Biomarkers, Neuroscience, Biogen

Piyush Bajaj, PhD, Scientist II, Investigative Toxicology, Drug Safety Research and Evaluation, Takeda Pharmaceuticals

Pooja Jain, MSc, MBA, Product Manager, R&D Solutions, Elsevier

Priyanka Kulkarni, PhD, Scientist, Pharmacokinetics and Drug Metabolism, Amgen, Inc.

Qin Wang, PhD, Principal Scientist, Translational Sciences, Biogen

Quamrul Hassan, PhD, Group Leader, Molecular and Cellular Pharmacology, EMD Serono

Rafael Fernandez, PhD, Principal Scientist, Pharmacology, Merck Research Laboratories

Ramesh Jayaraman, CSO, TheraIndx Lifesciences Pvt Ltd

Randolph Corteling, PhD, Head of Research, R&D, ReNeuron, Ltd.

Rangaraj Narayanan, PhD, Director, Drug Metabolism and Pharmacokinetics, Shire Pharmaceuticals

Raymond Chung, PhD, Biomedical Research Scientist, Cardiovascular Research, Regeneron Pharmaceuticals

Regis Doyonnas, PhD, Senior Principal Scientist, Primary Pharmacology Group, High Content Screening Lead, Worldwide R&D, Pfizer

Renato (Ron) Scialis, PhD, Senior Research Investigator, Preclinical Candidate Optimization, Bristol-Myers Squibb

Richard J. Price, PhD, Professor, Biomedical Engineering, University of Virginia

Ricky Solorzano, CEO, Allevi, Inc.

Robert A. Rollins, PhD, Associate Director, Oncology Research & Development, Pfizer

Robert C. Switzer, III, PhD, President, CSO, NeuroScience Associates, Inc.

Roderick L. Beijersbergen, PhD, Group Leader, Division of Molecular Carcinogenesis and Head, NKI Robotics and Screening Center, The Netherlands Cancer Institute

Ronald Alfa, MD, PhD, Vice President, Discovery & Product, Recursion Pharmaceuticals

Ronald Herbst, PhD, Vice President, R&D and Head, Oncology Research, MedImmune

Ronald Tomlinson, Associate Principal Scientist, Discovery Sciences – Chemical Biology, AstraZeneca

Ruben Boado, PhD, Vice President, Research & Development/Co-Founder, ArmaGen, Inc.

Rui Wang, PhD, Senior Scientist, Department of Immunology, AbbVie Bioresearch Center

Ruth Maclean, Senior Client Manager, Charles River

Ryan Nolan, PhD, Research Fellow, Takeda Pharmaceuticals International Co.

S. Joshua Swamidass, MD, PhD, Assistant Professor, Department of Immunology and Pathology, Division of Laboratory and Genomic Medicine; Faculty Lead, Translational Informatics, Institute for Informatics, Washington University

Samantha A. Meenach, PhD, Assistant Professor, Department of Chemical Engineering, Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island

Samira Musah, PhD, Dean’s Postdoctoral Fellow, Wyss Institute at Harvard University and Harvard Medical School

Samit Bhattacharya, PhD, Senior Principal Scientist, World Wide Medicinal Chemistry, Pfizer

Sarah Boswell, PhD, Director of Sequencing Technologies, Laboratory of Systems Pharmacology and Director, Single-Cell Sequencing Core, Harvard Medical School

Saso Cemerski, PhD, Principal Scientist, Merck Research Labs

Sean Lawler, PhD, Assistant Professor & Managing Director, Harvey Cushing Neurooncology Laboratories, Neurosurgery, Brigham and Women’s Hospital

Serguei Kozlov, PhD, MBA, PMP, Principal Scientist/PM, Team Leader PTO, Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research (NCI)

Shane Horman, PhD, Research Investigator III, Genomic Institute of the Novartis Research Foundation

Shantanu Singh, PhD, Senior Group Leader, Imaging Platform, Broad Institute

Shay Soker, PhD, Professor, Regenerative Medicine, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine

Shila Mekhoubad, PhD, Scientist II, Stem Cell Research, Biogen

Shuang Chen, PhD, Postdoctoral Fellow, Oncology Research Unit, Pfizer

Simone Calzolari, MSc, PhD, Co-Founder, Chief Commercial Officer, ZeClinics S.L.

Siva Kumar Belliraj, PhD, Associate Professor, Department of Chemistry, Sri Sathya Sai Institute of Higher Learning

Sourav Ghosh, PhD, Associate Professor, Neurology and Pharmacology, Yale University School of Medicine

Srivatsan Raghavan, MD, PhD, Instructor, Department of Medical Oncology, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute

Stefan Braam, PhD, Technical Director, Ncardia

Stefan Wilhelm, PhD, Assistant Professor, Stephenson School of Biomedical Engineering, University of Oklahoma

Stéphanie Boué, Manager Scientific Transparency & Verification, PMI R&D, Philip Morris Products S.A., Part of Philip Morris International Group

Stéphanie Decollogne, PhD, Senior Manager, Preclinical & Toxicology, Clinical Development, Nanobiotix

Stephanie Mohr, PhD, Lecturer, Genetics & Director, Drosophila RNAi Screening Center at Harvard Medical School

Stephen S. Ferguson, PhD, Chemist, Division of the National Toxicology Program (NTP), Biomolecular Screening Branch (BSB) & NTP Laboratories, National Institute of Environmental Health Sciences (NIEHS)

Stevin Zorn, PhD, President and CEO, MindImmune Therapeutics, Inc.

Svetlana Belyanskaya, PhD, Scientific Leader, Encoded Library Technologies, R&D Platform Technology & Science, GSK Boston

Swetha Srinivasan, PhD, Postdoctoral Fellow, Translational Immunology, AbbVie, Inc.

Takaomi C. Saido, PhD, Laboratory Head, Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute

Terry Kenakin, PhD, Professor, Department of Pharmacology, University of North Carolina School of Medicine

Terry Van Vleet, PhD, DABT, Head of Molecular and Computational Toxicology, Department of Preclinical Safety, Abbvie

Thierry Dorval, PhD, HCS Group Leader, Institut de Recherches Servier

Thomas M. Monticello, DVM, PhD, Executive Director, Comparative Biology and Safety Sciences, Amgen

Tim Bauler, PhD, Assistant Professor, Department of Biomedical Sciences, Western Michigan University Homer Stryker M.D. School of Medicine

Timothy Majarian, Associate Computational Biologist, Broad Institute

Tom Sundberg, PhD, Senior Research Scientist I, Center for the Development of Therapeutics, Broad Institute of MIT and Harvard

Tomoki Yoneyama, PhD, Senior Scientist 1, DMPK, Takeda

Tuulia Huhtala, PhD, Head, Biomarkers and in vitro Biology, Discovery, Charles River

Ulrich Elling, PhD, Principle Investigator, Institute of Molecular Biotechnology Austria (IMBA)

Vladimir Torchilin, PhD, Distinguished Professor and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Bouvé College of Health Sciences, Northeastern University

Warren J. Leonard, MD, NIH Distinguished Investigator, Chief, Laboratory of Molecular Immunology and Director, Immunology Center, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health

Wayne W. Hancock, MD, PhD, Professor of Pathology and Chief of Transplant Immunology, Children’s Hospital of Philadelphia and University of Pennsylvania

Wen Kang, PhD, Principal Scientist, Safety Assessment & Laboratory Animal Resources, Merck & Co., Inc.

Will Proctor, PhD, Senior Scientist, Head of Investigative Toxicology, Department of Safety Assessment, Genentech

William A. Banks, MD, Associate Chief of Staff – R&D, Geriatric Research Education & Clinical Center, Veterans Affairs Medical Center & University of Washington

William Daly, PhD, Managing Director & Faculty Scientist, Orthopedics and Rehabilitation, University of Wisconsin - Madison

William Proctor, PhD, Senior Scientist, Head of Investigative Toxicology, Department of Safety Assessment, Genentech

Xingfeng Bao, PhD, Head, Immuno-Oncology, Integrated Biology Engine, Eisai AiM Institute, Eisai, Inc.

Xingxing Zang, PhD, Louis Goldstein Swan Endowed Chair and Professor, Microbiology and Immunology & Medicine, Albert Einstein College of Medicine

Ying Wang, PhD, Principal Scientist, Department of Chemistry & Technology, AbbVie

Yu Shrike Zhang, PhD, Research Faculty & Associate Bioengineer, Division of Engineering in Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School & Harvard-MIT Division of Health Sciences and Technology

Yuan Chen, PhD, Principal Scientist, DMPK, Genentech

Zhao Chen, PhD, Investigator III, Exploratory Immuno-Oncology, Novartis Institutes for BioMedical Research

Zhengyin Yan, PhD, Senior Scientist, Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc.